Success Metrics

Clinical Success Rate

100.0%

Based on 1 completed trials

Completion Rate

100%(1/1)

Active Trials

1(25%)

Results Posted

100%(1 trials)

Phase Distribution

Ph phase_1

50%

Ph phase_2

50%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution4 total trials

Phase 1Safety & dosage

2(50.0%)

Phase 2Efficacy & side effects

2(50.0%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

33.3%

1 of 3 finished

Non-Completion Rate

66.7%

2 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(1)

Completed(1)

Terminated(2)

Detailed Status

Withdrawn2

Completed1

Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

Phase 2

Trials by Phase

Phase 12 (50.0%)

Phase 22 (50.0%)

Trials by Status

completed125%

active_not_recruiting125%

withdrawn250%

Recent Activity

1 active trials

Showing 4 of 4

active_not_recruitingphase_2

Study of JK07 in Patients With Chronic Heart Failure

NCT06369298

withdrawnphase_2

Study of JK07 in Patients With Heart Failure and WHO Group 2 Combined Post- and Pre-Capillary Pulmonary Hypertension

NCT07221513

completedphase_1

Study of JK07 in Subjects With Heart Failure With Reduced Ejection Fraction (HFrEF)

NCT04210375

withdrawnphase_1

Single-Ascending Dose Study of JK07 in Subjects With HFpEF

NCT05322616

Clinical Trials (4)

Showing 4 of 4 trials

NCT06369298Phase 2

Study of JK07 in Patients With Chronic Heart Failure

Active Not Recruiting

NCT07221513Phase 2

Study of JK07 in Patients With Heart Failure and WHO Group 2 Combined Post- and Pre-Capillary Pulmonary Hypertension

Withdrawn

NCT04210375Phase 1

Study of JK07 in Subjects With Heart Failure With Reduced Ejection Fraction (HFrEF)

Completed

NCT05322616Phase 1

Single-Ascending Dose Study of JK07 in Subjects With HFpEF

Withdrawn

All 4 trials loaded

Drug Details

Intervention Type: DRUG
Total Trials: 4